Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia
NCT07726576
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG:
Venetoclax in association with 3+7 and midostaurin
Sponsor
University Hospital, Bordeaux